ABSTRACT
Dentro de las manifestaciones extraintestinales de la enfermedad inflamatoria intestinal (EII), el pioderma gangrenoso (PG) plantea con frecuencia dificultades terapéuticas. Describimos 2 casos de PG asociados a enfermedad inflamatoria intestinal, con buena respuesta al tratamiento con infliximab (AU)
Among the extraintestinal manifestations of inflammatory bowel disease (IBD), pyoderma gangrenosum (PG) often poses a therapeutic challenge. We describe two cases of PG associated with inflammatory bowel disease, who responded to treatment with Infliximab (AU)
Subject(s)
Humans , Male , Middle Aged , Pyoderma Gangrenosum/complications , Pyoderma Gangrenosum/diagnosis , Pyoderma Gangrenosum/drug therapy , Inflammatory Bowel Diseases/complications , Inflammatory Bowel Diseases/diagnosis , Crohn Disease/complications , Skin Ulcer/complications , Skin Ulcer/drug therapy , Pyoderma Gangrenosum/physiopathology , Inflammatory Bowel Diseases/physiopathology , Inflammatory Bowel Diseases , Colonoscopy , Parenteral Nutrition/methods , Parenteral NutritionABSTRACT
Among the extraintestinal manifestations of inflammatory bowel disease (IBD), pyoderma gangrenosum (PG) often poses a therapeutic challenge. We describe two cases of PG associated with inflammatory bowel disease, who responded to treatment with Infliximab.
